![](/images/graphics-bg.png)
Long-Term Intravenous Ketamine for Analgesia in a Child with Severe Chronic Intestinal Graft versus Host Disease
Joint Authors
Busse, Jennifer
Phillips, Leroy
Schechter, William
Source
Case Reports in Anesthesiology
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-12-08
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Ketamine is reported to be an effective adjuvant to opioids in the treatment of refractory cancer pain; however, the use of high doses of ketamine for extended periods in pediatric patients has not been described.
We present a five-year-old male with grade IV intestinal GVHD whose abdominal pain required both hydromorphone and ketamine for a period of over four months.
There was no evidence of hepatotoxicity, hemorrhagic cystitis, or other adverse effects.
Possible withdrawal symptoms were mild and were readily mitigated by gradually weaning ketamine.
American Psychological Association (APA)
Busse, Jennifer& Phillips, Leroy& Schechter, William. 2015. Long-Term Intravenous Ketamine for Analgesia in a Child with Severe Chronic Intestinal Graft versus Host Disease. Case Reports in Anesthesiology،Vol. 2015, no. 2015, pp.1-4.
https://search.emarefa.net/detail/BIM-1058072
Modern Language Association (MLA)
Busse, Jennifer…[et al.]. Long-Term Intravenous Ketamine for Analgesia in a Child with Severe Chronic Intestinal Graft versus Host Disease. Case Reports in Anesthesiology No. 2015 (2015), pp.1-4.
https://search.emarefa.net/detail/BIM-1058072
American Medical Association (AMA)
Busse, Jennifer& Phillips, Leroy& Schechter, William. Long-Term Intravenous Ketamine for Analgesia in a Child with Severe Chronic Intestinal Graft versus Host Disease. Case Reports in Anesthesiology. 2015. Vol. 2015, no. 2015, pp.1-4.
https://search.emarefa.net/detail/BIM-1058072
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1058072